Micro-Needling Radio Frequency

Procedures With No Or Miminal Downtime

Sylfirm Microneedling Radiofrequency

Microneedling Radiofrequency treats melasma, diffuse redness, rosacea and post-inflammatory hyperpigmentation. It is also effective in reducing fine lines, big pores, acne scars, brightening skin tone, and rejuvenating the skin in general.

Developed in Silicon Valley, Sylfirm uses multiple tiny electrodes to transmit a therapeutic electromagnetic field of energy that safely penetrates the dermal layer. The microneedling process triggers skin regeneration and collagen production, while the addition of radiofrequency energy further stimulates collagen production and skin’s natural healing response. Furthermore, the innovative SR3 (Selective Regional Regeneration Radio Repeated Pulse) technology reacts only to abnormal blood vessels and basement membrane, which normalises VEGF production (a protein that stimulates production of blood vessels) and remodels tissue membrane for dermal rejuvenation.

Many individuals have a compromised basement membrance due to sun exposure and intrinsic ageing. Remodelling this very layer between the epidermis and dermis prevents the migration of pigment cells to the deeper dermal layer. Sylfirm targets the root causes of melasma by regulating hyperactive melanocytes (pigment cells), strengthening damaged basement membrane, removing abnormal blood vessels in the skin, and increasing collagen and young fibroblast production.

  • Melasma
  • Rosacea
  • Facial redness
  • Enlarged pores
  • Superficial fine lines
  • Acne marks

You may observe some lightening and a smoother skin texture after the first session. Full results are usually observed after 5 sessions, the treatment sessions are performed once every 3 weeks.

The treatment is virtually painless as numbing cream will be applied beforehand.
Immediately following the treatment, there may be some mild redness and swelling which typically resolves within an hour.
Most patients are able to resume activities immediately post-treatment.